For the quarter ending 2026-03-31, ESMC made $2,608,523 in revenue. $1,206,405 in net income. Net profit margin of 46.25%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues, net | 2,608,523 | 3,591,447 | 2,675,321 | 2,384,480* |
| Cost of product and service sold | 1,661,861 | 2,035,395 | 1,554,579 | 1,211,769* |
| Marketing, general and administrative | 1,336,017 | 1,326,132 | 1,107,395 | 1,232,624.5* |
| Research and development | 29,908 | 131,182 | 216,098 | 307,931.5* |
| Total costs and expenses | 3,027,786 | 3,492,709 | 2,878,072 | 2,752,325* |
| (gain) income from operations | -419,263 | 98,738 | -202,751 | -367,845* |
| Gain (loss) on disposition of intangible assets | 2,813,525 | - | - | - |
| Other nonoperating income (expense) | -17,622 | -285 | -32,797 | -1,250* |
| Interest expense, nonoperating | 3,204 | 776 | 4,304 | 10,656* |
| Total other (expense) income | - | -1,061 | -37,101 | -11,906* |
| Income tax expense (benefit) | 0 | 0 | 0 | 0* |
| Net income | 2,373,436 | 97,677 | -239,852 | -379,751 |
| Less income allocated to convertible preferred stocks | 12,723 | 13,006 | 13,006 | 12,882* |
| Undistributed earnings (gain) allocated to participating securities, basic | 1,154,308 | 40,884 | - | -207,730* |
| Net income applicable to common stockholders | 1,206,405 | 43,787 | -252,858 | -184,903 |
| Basic EPS | 0.16 | 0.01 | -0.03 | -0.025 |
| Diluted EPS | 0.16 | 0.01 | -0.03 | -0.013 |
| Basic Average Shares | 7,415,329 | 7,415,329 | 7,415,329 | 7,415,329 |
| Diluted Average Shares | 14,510,436 | 14,423,729 | 7,415,329 | 14,252,202* |
ESCALON MEDICAL CORP (ESMC)
ESCALON MEDICAL CORP (ESMC)